SCHEMBL30541131

SCHEMBL30541131

CC[C@H](C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)[C@@H](C)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CASP3 P42574 6/20 0.61
▸ CASP1 P29466 4/20 0.61
▸ CASP9 P55211 4/20 0.61
▸ CASP4 P49662 2/20 0.61
▸ CASP5 P51878 2/20 0.61
▸ CASP6 P55212 2/20 0.61
▸ CASP8 Q14790 2/20 0.61
▸ CASP10 Q92851 2/20 0.61
▸ CASP7 P55210 2/20 0.59
▸ CTSL P07711 2/20 0.53
▸ CTSS P25774 2/20 0.53
▸ CTSB P07858 2/20 0.53
▸ MEN1 O00255 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ LMNA P02545 1/20 0.52
▸ ENPEP Q07075 5/20 0.50
▸ PSMB5 P28074 1/20 0.49
▸ BACE1 P56817 1/20 0.49
▸ CTSK P43235 1/20 0.49
▸ REN P00797 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31248472 0.95 CASP3 (0.63) CASP3CASP1CASP9CASP4CASP5
SCHEMBL23613622 0.91 CASP3 (0.56) CASP3CASP1CASP9CASP4CASP5
SCHEMBL2040978 0.91 CASP3 (0.57) CASP3CASP1CASP9CASP4CASP5
SCHEMBL6669609 0.89 CTSB (0.63) CASP3CASP1CASP9CASP4CASP5
SCHEMBL15462716 0.87 CASP3 (0.64) CASP3CASP1CASP9CASP4CASP5
SCHEMBL29362585 0.86 CASP3 (0.76) CASP3CASP1CASP9CASP4CASP5
SCHEMBL21137611 0.86 CASP3 (0.52) CASP3CASP1CASP9CASP4CASP5
SCHEMBL21137607 0.86 CASP3 (0.52) CASP3CASP1CASP9CASP4CASP5
SCHEMBL17450056 0.86 CASP3 (0.52) CASP3CASP1CASP9CASP4CASP5
SCHEMBL15359185 0.86 CASP3 (0.52) CASP3CASP1CASP9CASP4CASP5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250163459-A1 IMPROVED CELL LINES AND METHODS FOR THE PRODUCTION OF ADENO-ASSOCIATED VECTORS CEVEC PHARMACEUTICALS GMBH (DE) 2025-05-22 — — US claimed
CN-118804973-A Improved cell lines and methods for producing adeno-associated vectors 塞维克制药有限责任公司 2024-10-18 — — CN claimed
EP-4239063-A1 IMPROVED CELL LINES AND METHODS FOR THE PRODUCTION OF ADENO-ASSOCIATED VECTORS CEVEC Pharmaceuticals GmbH (DE) 2023-09-06 — — EP claimed
US-20250163459-A1 IMPROVED CELL LINES AND METHODS FOR THE PRODUCTION OF ADENO-ASSOCIATED VECTORS CEVEC PHARMACEUTICALS GMBH (DE) 2025-05-22 — — US disclosed
CN-118804973-A Improved cell lines and methods for producing adeno-associated vectors 塞维克制药有限责任公司 2024-10-18 — — CN disclosed
EP-4239063-A1 IMPROVED CELL LINES AND METHODS FOR THE PRODUCTION OF ADENO-ASSOCIATED VECTORS CEVEC Pharmaceuticals GmbH (DE) 2023-09-06 — — EP disclosed
Send feedback